» Articles » PMID: 37402503

and Evaluation of the Antimicrobial, Antioxidant, Cytotoxic, Hemolytic Activities and POM/DFT/DNA-binding and Pharmacokinetic Analyses of New Sulfonamide Bearing Thiazolidin-4-ones

Abstract

In this work, Schiff bases and Thiazolidin-4-ones, were synthesized using Sonication and Microwave techniques, respectively. The Schiff base derivatives () were synthesized the reaction of Sulfathiazole () with benzaldehyde derivatives (), followed by the synthesis of 4-thiazoledinone () derivatives by cyclizing the synthesized Schiff bases through thioglycholic acid. All the synthesized compounds were characterized by spectroscopic techniques such as FT IR, NMR and HRMS. The synthesized compounds were tested for their antimicrobial and antioxidant and cytotoxicity and hemolysis ability. The synthesized compounds displayed better antimicrobial and antioxidant activity and low toxicity in comparison to reference drugs and negative controls, respectively. The hemolysis test revealed the compounds exhibit lower hemolytic effects and hemolytic values are comparatively low and the safety of compounds is in comparison with standard drugs. Theoretical calculations were carried out by using the molecular operating environment (MOE) and Gaussian computing software and observations were in good agreement with the and biological activities. Petra/Osiris/Molinspiration (POM) results indicate the presence of three combined antibacterial, antiviral and antitumor pharmacophore sites. The molecular docking revealed the significant binding affinities and non-bonding interactions between the compounds and Erwinia Chrysanthemi (PDB ID: 1SHK). The molecular dynamics simulation under physiological conditions revealed a stable conformation and binding pattern in a stimulating environment. HighlightsNew series of Thaiazolidin-4-one derivatives have been synthesized.Sonication and microwave techniques are used.Antimicrobial, Antioxidant, cytotoxicity, and hemolysis activities were observed for all synthesized compounds.Molecular Docking and DFT/POM analyses have been predicted.Communicated by Ramaswamy H. Sarma.

Citing Articles

Neuroprotective thiazole sulfonamides against 6-OHDA-induced Parkinsonian model: biological and pharmacokinetic assessments.

Ruankham W, Pingaew R, Prachayasittikul V, Worachartcheewan A, Sathuphong S, Apiraksattayakul S RSC Adv. 2025; 15(6):4281-4295.

PMID: 39931414 PMC: 11809491. DOI: 10.1039/d4ra04941a.


Fluopyram analogues containing an indole moiety: synthesis, biological activity and molecular docking study.

Huang Z, Huang Q, Wei H, Chen J, Wang J, Song G Mol Divers. 2025; .

PMID: 39832082 DOI: 10.1007/s11030-025-11106-9.


Synthesis and antimicrobial evaluation of a new hybrid bis-cyanoacrylamide-based-piperazine containing sulphamethoxazole moiety against rheumatoid arthritis-associated pathogens.

Soliman M, Elwahy A, Sayed A, Ibrahim M, Dawoud M, Ali S Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39831977 DOI: 10.1007/s00210-024-03780-7.


Exploring the Inhibitory Potential of Compounds Against -Acetylglucosamine (Mur) Receptor: Insights Into Antibacterial Activity and Drug-Likeness.

Gartika M, Tumilaar S, Dharsono H, Nurdin D, Kurnia D ScientificWorldJournal. 2024; 2024:3569811.

PMID: 39654692 PMC: 11628175. DOI: 10.1155/tswj/3569811.


Novel candidates synthesis of indenopyrazole, indenoazine and indenothiophene, with anticancer and studies.

Abdellattif M, Assy M, Elfarargy A, Ramadan F, Elgendy M, Emwas A Future Med Chem. 2024; 16(14):1429-1447.

PMID: 39190476 PMC: 11352785. DOI: 10.1080/17568919.2024.2351350.